Literature DB >> 33737254

Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions.

Maria Luisa Caballero1, Matthew S Krantz2, Santiago Quirce3, Elizabeth J Phillips4, Cosby A Stone5.   

Abstract

Excipients are necessary as a support to the active ingredients in drugs, vaccines, and other products, and they contribute to their stability, preservation, pharmacokinetics, bioavailability, appearance, and acceptability. For both drugs and vaccines, these are rare reactions; however, for vaccines, they are the primary cause of immediate hypersensitivity. Suspicion for these "hidden dangers" should be high, in particular, when anaphylaxis has occurred in association with multiple chemically distinct drugs. Common excipients implicated include gelatin, carboxymethylcellulose, polyethylene glycols, and products related to polyethylene glycols in immediate hypersensitivity reactions and propylene glycol in delayed hypersensitivity reactions. Complete evaluation of a suspected excipient reaction requires detailed information from the product monograph and package insert to identify all ingredients that are present and to understand the function and structure for these chemicals. This knowledge helps develop a management plan that may include allergy testing to identify the implicated component and to give patients detailed information for future avoidance of relevant foods, drugs, and vaccines. Excipient reactions should be particularly considered for specific classes of drugs where they have been commonly found to be the culprit (eg, corticosteroids, injectable hormones, immunotherapies, monoclonal antibodies, and vaccines). We provide a review of the evidence-based literature outlining epidemiology and mechanisms of excipient reactions and provide strategies for heightened recognition and allergy testing.
Copyright © 2021 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergy; Anaphylaxis; Biologic; Carboxymethylcellulose (CMC); Corticosteroid; Drug; Excipient; Gelatin; Inactive ingredient; Polyethylene glycol (PEG); Polysorbate; Vaccine; alpha-gal

Mesh:

Substances:

Year:  2021        PMID: 33737254      PMCID: PMC8355062          DOI: 10.1016/j.jaip.2021.03.002

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  157 in total

1.  IgE-mediated systemic reactions to gelatin included in the varicella vaccine.

Authors:  M Sakaguchi; T Yamanaka; K Ikeda; Y Sano; H Fujita; T Miura; S Inouye
Journal:  J Allergy Clin Immunol       Date:  1997-02       Impact factor: 10.793

2.  Anaphylaxis to medications containing meat byproducts in an alpha-gal sensitized individual.

Authors:  Christine Muglia; Indrani Kar; Min Gong; Evelyn R Hermes-DeSantis; Catherine Monteleone
Journal:  J Allergy Clin Immunol Pract       Date:  2015-05-20

3.  Life-threatening intraoperative anaphylaxis to gelatin in Floseal during pediatric spinal surgery.

Authors:  Niti S Agarwal; Collette Spalding; Mervat Nassef
Journal:  J Allergy Clin Immunol Pract       Date:  2014-07-03

4.  Intraoperative anaphylaxis likely due to Gelfoam in a pediatric patient undergoing liver biopsy.

Authors:  Karen A Robbins; Corinne A Keet
Journal:  Ann Allergy Asthma Immunol       Date:  2015-04-14       Impact factor: 6.347

5.  Immediate hypersensitivity reaction to pegylated liposomal doxorubicin: management and outcome in four patients.

Authors:  Saskia Ingen-Housz-Oro; Anne Pham-Ledard; Pauline Brice; Bénédicte Lebrun-Vignes; Ouidad Zehou; Delphine Reitter; Caroline Ram-Wolff; Nicolas Dupin; Martine Bagot; Olivier Chosidow; Marie Beylot-Barry
Journal:  Eur J Dermatol       Date:  2017-06-01       Impact factor: 3.328

6.  Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients.

Authors:  Maria A Bruusgaard-Mouritsen; Jeanne D Johansen; Lene H Garvey
Journal:  Clin Exp Allergy       Date:  2021-01-15       Impact factor: 5.018

7.  Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions.

Authors:  Esther A Coors; Heidi Seybold; Hans F Merk; Vera Mahler
Journal:  Ann Allergy Asthma Immunol       Date:  2005-12       Impact factor: 6.347

8.  Anaphylaxis to the carbohydrate carboxymethylcellulose in parenteral corticosteroid preparations.

Authors:  P L Bigliardi; J Izakovic; J M Weber; A J Bircher
Journal:  Dermatology       Date:  2003       Impact factor: 5.366

Review 9.  Hypersensitivity reactions to chemotherapeutic drugs.

Authors:  Gillian M Shepherd
Journal:  Clin Rev Allergy Immunol       Date:  2003-06       Impact factor: 8.667

Review 10.  Evaluation and Management of Penicillin Allergy: A Review.

Authors:  Erica S Shenoy; Eric Macy; Theresa Rowe; Kimberly G Blumenthal
Journal:  JAMA       Date:  2019-01-15       Impact factor: 56.272

View more
  6 in total

Review 1.  Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies.

Authors:  Shuen-Iu Hung; Ivan Arni C Preclaro; Wen-Hung Chung; Chuang-Wei Wang
Journal:  Biomedicines       Date:  2022-05-28

Review 2.  What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later.

Authors:  Ana M Copaescu; Jaime S Rosa Duque; Elizabeth Jane Phillips
Journal:  Ann Allergy Asthma Immunol       Date:  2022-04-04       Impact factor: 6.248

Review 3.  Rapid progress in our understanding of COVID-19 vaccine allergy: A cause for optimism, not hesitancy.

Authors:  Aleena Banerji; Allison E Norton; Kimberly G Blumenthal; Cosby A Stone; Elizabeth Phillips
Journal:  J Allergy Clin Immunol       Date:  2022-04-07       Impact factor: 14.290

4.  Anaphylaxis to SARS-CoV-2 Vaccines in the Setting of a Nationwide Passive Epidemiological Surveillance Program.

Authors:  Carla Toledo-Salinas; Selma Cecilia Scheffler-Mendoza; Lina Maria Castano-Jaramillo; José Antonio Ortega-Martell; Blanca Estela Del Rio-Navarro; Ana María Santibáñez-Copado; José Luis Díaz-Ortega; Raúl Baptista-Rosas; Paulina Sánchez-Novoa; Miguel García-Grimshaw; Sergio Iván Valdés-Ferrer; Gustavo Reyes-Terán; David Alejandro Mendoza-Hernández
Journal:  J Clin Immunol       Date:  2022-08-17       Impact factor: 8.542

Review 5.  Hypersensitivity to polyethylene glycol in adults and children: An emerging challenge.

Authors:  Annamaria Bianchi; Paolo Bottau; Elisabetta Calamelli; Silvia Caimmi; Giuseppe Crisafulli; Fabrizio Franceschini; Lucia Liotti; Francesca Mori; Claudia Paglialunga; Francesca Saretta; Mariangela Tosca; Fabio Cardinale; Amelia Licari; Michele Miraglia Del Giudice; Carlo Caffarelli
Journal:  Acta Biomed       Date:  2021-11-29

6.  AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy.

Authors:  Syed B Ali; Griffith Perkins; Dongjae Ryoo; Maverick Lee; Matthew Tunbridge; Chino Yuson; William Smith; Pravin Hissaria; Thanh-Thao Le
Journal:  Allergy Asthma Clin Immunol       Date:  2022-03-10       Impact factor: 3.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.